We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Technology is becoming a common component to any drug delivery mechanism. With West’s ongoing partnership with connected health expert, HealthPrize, a new course to improve patient outcomes has been charted. By connecting West drug delivery systems with the training, education and rewards from the HealthPrize model, we are addressing some of the most fundamental challenges surrounding adherence.
In a 2013 HealthPrize patient survey, 45% of patients responded that they would rather take out the trash, 27% of patients would rather get a shot, and 10% of patients would rather get a cavity filled, than take their medication. Not only do these statistics describe the patient perspective in a relatable manner, but they also show the tremendous potential for innovative solutions like those West and HealthPrize are working to bring to the marketplace.
As West continues to develop leading drug delivery systems, so too does HealthPrize continue to develop a customizable, interactive, patient model that incorporates gamification and fun into an experience that may be considered a grueling activity for many. HealthPrize understands the behavioral economics of the patient perspective on adherence for injection systems, and continues to educate patients and provide rewards for adhering to drug regimens.
Chief Medical Officer and Co-founder of HealthPrize, Katrina Firlik, MD, defines the success of HealthPrize as summarizing the short-term benefits of awarding patients with tangible rewards to encourage best practices for patients to ultimately achieve healthier, improved outcomes in patients. Together, both organizations are dedicated to help improve behaviors related to non-adherence and doing so in an easy, fun and rewarding way.
<p>By Katrina Firlik, MD<br>Chief Medical Officer<br>HealthPrize Technologies</p><p>Although modern pharmaceuticals and advanced drug delivery systems save and improve the lives of millions of people around the world, there are countless others whose lives are not saved or improved—because they don’t take the medication at all, or often enough. Former Surgeon General C. Everett Koop summed it up best: “Drugs don’t work in patients who don’t take them.”</p>
<em>West is pleased to welcome guest blogger Katrina Firlik, MD, Chief Medical Officer and Co-Founder of </em><a href="https://healthprize.com/"><span style="text-decoration: underline;"><em>HealthPrize Technologies</em></span></a><em>. This is the first installment in a four-part series on the West/HealthPrize collaboration.</em>
Many of the newer biologic products being developed are for long-term administration in chronic disease conditions, including oncology, autoimmune disorders and high cholesterol. Historically, these biologics have been administered by costly intravenous (IV) injection in a hospital, clinic or doctor’s office.
West’s Tibor Hlobik and Chris Evans will present at the 2015 Drug Delivery Partnership conference, January 28-30 in Boca Raton, FL.
West is pleased to welcome guest blogger John Ragland, Jr., Chief Product Officer, <a href="https://healthprize.com/"><span style="color: #6d6d6d; text-decoration: underline;">HealthPrize Technologies</span></a>. This is the third installment in a series on the West/HealthPrize collaboration.
English
Chinese
